Mendel Money Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,005
Closed -$209K 118
2022
Q1
$209K Sell
10,005
-2,875
-22% -$62.7K 0.1% 122
2021
Q4
$330K Buy
12,880
+1,050
+9% +$29K 0.19% 60
2021
Q3
$373K Buy
11,830
+650
+6% +$22.5K 0.23% 56
2021
Q2
$447K Buy
+11,180
New +$454K 0.28% 48

Other funds holding MSOS

Mendel Money Management's MSOS Position: Q2 2022 in Review

Mendel Money Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q2 2022, closing a stake of 10,005 shares — an estimated $209K sold.

Mendel Money Management first reported a position in MSOS in Q2 2021 and held it in 4 quarters. The position peaked at $447K in Q2 2021. 168 funds tracked by Wall St. Rank hold MSOS as of Q2 2022.

  • Mendel Money Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q2 2022 after selling out during the quarter.
  • Mendel Money Management sold 10,005 AdvisorShares Pure US Cannabis ETF shares in Q2 2022, an estimated $209K.
  • Mendel Money Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 4 quarters.
  • Mendel Money Management's AdvisorShares Pure US Cannabis ETF position peaked at $447K in Q2 2021.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2022.

Based on Mendel Money Management's 13F filing for Q2 2022, filed 15 Aug 2022.